Purpose This retrospective study aims to compare the effectiveness and safety of four oral
antiviral drugs including Simnotrelvir/Ritonavir, Nirmatrelvir/Ritonavir, Azvudine and …

Background In this study, we aimed to compare the effectiveness and adverse reactions of
nirmatrelvir/ritonavir and molnupiravir in high-risk outpatients with coronavirus disease 2019 …

Background and aim Two oral antivirals (Nirmatrelvir-ritonavir and Azvudine) are widely
used in China practice during the Omicron wave of the pandemic. However, little evidence …

Background To address the need for treatments for patients with coronavirus disease 2019
(COVID-19), 3 therapies have been given either full approval or Emergency Use …

Background Molnupiravir and nirmatrelvir-ritonavir have emerged as promising options for
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …

Background: Most COVID-19 patients have mild or moderate illnesses that can progress to
severe illness, leading to hospitalization and/or mortality. The use of antivirals to prevent the …

Background: According to the Evaluation of Protease Inhibition for COVID-19 in High-Risk
Patients (EPIC-HR) study, compared with a placebo, nirmatrelvir/ritonavir significantly …

Background Using a retrospective cohort study design, we aimed to evaluate the
effectiveness of molnupiravir and nirmatrelvir/ritonavir in patients with SARS-CoV-2 who …

Objectives: This study reviewed factors influencing the length of hospital stay in adult
inpatients with confirmed Coronavirus disease (COVID-19) who were treated with …

Purpose To compare the effectiveness of azvudine and nirmatrelvir/ritonavir for the treatment
of coronavirus disease (COVID-19). Patients and Methods We conducted a retrospective …